medtron inc said see pct growth sale and earn for year end april 1988 analyst meet compani said for year end april 1987 will earn about mln dlrs about dlrs share sale about 500 mln dlrs year ago period compani earn mln dlrs dlrs share sale 402 mln dlrs winston wallin medtron chairman said compani will improv market share fiscal 1988 cardiac pacemak and expand it cardiovascular therapeut product line wallin caution analyst not quick chang per share estim for compani said medtron will have heavi sale and market expens fiscal 1988 said compani intend reinvest it earn it busi and not it dividend sharehold better off grow busi rather reinvest dividend share repurchas said wallin said see medtron share total worldwid pacemak market increas pct fiscal 1988 from pct fiscal 1987 said worldwid market for cardiovascualr therapeut product which includ pacemak valv cathet and laser will valu about billion dlrs 1990 and will doubl 1995 wallin said object hold new product and start build market share have beg borrow steal into new market past medtron pacemak have been plagu with number problem lead product recal regul also have critic industri cite qualiti problem and needless overprescript pacemak have knowledg ani major problem pacemak lead wallin said intend establish compani qualiti leader industri glen nelson execut vice presid for medtron said compani intend diversifi intern and through acquisit compani area medtron expertis such drug deliveri system wallin said pct earn growth for fiscal 1988 doe not includ dilut from acquisit hope have some safeti provis won have ani major dilut from acquisit wallin also said compani will have virtual exclus rate respons pacemak for all fiscal 1988 compani market activitrax first singl chamber pacemak vari heartrat respons physic activ siemen west german compani also develop rate respons pacemak reuter 